Impact of tricuspid valve regurgitation on intermediate outcomes of degenerative mitral valve surgery Feb. 06, 2023 Overview Show transcript Overview Juan A. Crestanello, M.D., is a cardiovascular surgeon and department chair of Cardiovascular Surgery at Mayo Clinic in Rochester, Minnesota. Dr. Crestanello, who specializes in surgery for valvular heart disease, discusses the impact of tricuspid valve regurgitation on intermediate outcomes of degenerative mitral valve surgery. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentVideoNovel mitral therapies — A Mayo Clinic perspectiveArticleMayo Clinic Cardiovascular Surgery's specialized and technical approach to mitral valve surgery repairVideoRobotic versus minimally invasive mitral valve repair: A five-year comparison of surgical outcomes VID-20548575 Medical Professionals Impact of tricuspid valve regurgitation on immediate outcomes of degenerative mitral valve surgery